
S1172 Presence of NAFLD in Patients Receiving Immune Checkpoint Inhibitors Significantly Increases the Prevalence of Immune Medicated Hepatotoxicity
Author(s) -
Osama Hamid,
Ahmed Eltelbany,
Abdul Hakim Mohammed,
Imad Asaad
Publication year - 2021
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000778220.97096.b0
Subject(s) - medicine , adverse effect , immune system , fatty liver , liver injury , cancer , disease , immunology